Jinsuk Woo

Title: Innovations of Jinsuk Woo in Oligonucleotide Technology.

Introduction

Jinsuk Woo is an accomplished inventor based in Lynnwood, WA (US). He has made significant contributions to the field of oligonucleotide technology, particularly in the development of selective binding complementary oligonucleotides. His innovative work has implications for gene mapping and various diagnostic and therapeutic applications.

Latest Patents

Jinsuk Woo holds a patent for "Selective binding complementary oligonucleotides." This invention involves a matched pair of oligonucleotides (ODNs) that are complementary to a target sequence of duplex nucleic acid. The ODNs are designed with modified bases that form stable hydrogen bonds with their natural partner bases while not bonding stably with their modified counterparts. This unique design allows the matched pair of oligonucleotides to maintain a melting temperature of approximately 40 degrees Celsius or less under physiological conditions, while still forming stable hybrids with target sequences.

Career Highlights

Jinsuk Woo is associated with Epoch Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has been pivotal in enhancing the understanding and application of oligonucleotide technology in the medical field.

Collaborations

Throughout his career, Jinsuk Woo has collaborated with notable professionals, including Howard B. Gamper and Eugeny Alexander Lukhtanov. These collaborations have further enriched his research and contributed to the success of his innovations.

Conclusion

Jinsuk Woo's contributions to the field of oligonucleotide technology exemplify the impact of innovative thinking in scientific research. His patent on selective binding complementary oligonucleotides showcases the potential for advancements in gene mapping and therapeutic applications.